Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-03-06
2007-03-06
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C546S188000, C546S193000, C546S196000, C546S207000, C546S214000, C546S221000, C544S129000, C544S133000, C514S237200, C514S256000, C514S337000, C514S318000, C514S336000, C514S320000
Reexamination Certificate
active
10953788
ABSTRACT:
Compounds of formula (II) are antibacterial agents wherein Q represents a radical of the formula: —N(OH)CH(═O) or the formula: —C(═O)NH(OH); R1represents hydrogen, C1–C6alkyl or C1–C6alkyl substituted by one or more halogen atoms, or, except when Q is a radical of the formula: —N(OH)CH(═O), a hydroxy, C1–C6alkoxy, C1–C6alkenyloxy, amino, C1–C6alkylamino, or di-(C1–C6alkyl)amino group; R2represents a substituted or unsubstituted C1–C6alkyl, cycloalkyl(C1–C6alkyl)- or aryl(C1–C6alkyl)-group; and A represents a group of formula (IIA), or (IIB) wherein R4represents the side chain of a natural or non-natural alpha amino acid, and R5and R6when taken together with the nitrogen atom to which they are attached form a saturated heterocyclic first ring of 5 to 7 atoms as specified in the description.
REFERENCES:
patent: 6787522 (2004-09-01), Hunter et al.
patent: 08053403 (1996-02-01), None
patent: 91/02716 (1991-03-01), None
patent: 99/39704 (1999-08-01), None
patent: 99/57097 (1999-11-01), None
Broughton, et al.: “Studies Concerning the Antibiotic Actinonin”, J. Chem. Soc., Perkin Trans 1, vol. 9, 1975, pp. 857-860, XP002157880, XP002157880.
Devlin, John P., et al: “Antibiotic actinonin, V. Synthesis of structural analogs of actinonin b the anhydride-ester method”, J.Chem.Soc., Perkin Trans. 1 (1975),(9), 846-848, XP002157881.
Penning, Thomas D., et al.: “Kelatorphan and related analogs: potent and selective inhibitors of leukotriene A4 hydrolase”, Bioorg. Med. Chem. Lett. (1995), 5(21), 2157-2522,XP002157882.
Chen, et al.: “Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor”, BIOCHEMISTRY, vol. 39, Feb. 15, 2000, pp. 1256-1262, XP002158085.
Inaoka, et al.: “Propioxatins A and B, new enkephalinase B inhibitors”, J.Biochem. (Tokyo), vol. 104, 1988, pp. 706-711, XP000978993, table I, compd 4.
Bouboutou, et al.: “Inhibition of porcine synovial collengenase by actinonin and derivatives” Colloq. Inserm., vol. 174, 1989, pp. 341-344, XP000978992, Table I, Actinonin 2.
Inaoka, et al.: “propioxatins A and B, new enkephalinase B inhibitors”, J. Antiobiot., vol. 39, No. 10, 1986, pp. 1382-1385, XP000978947.
Keavey Kenneth Noel
Mounier Laurent
Pain Gilles Denis
Pratt Lisa Marie
British Biotech Pharmaceuticals
Habte Kahsay
LandOfFree
Antibacterial agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibacterial agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibacterial agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3753805